OR WAIT null SECS
January 31, 2022
Metagenomi has successfully raised $175 million for use toward its research pipeline.
January 28, 2022
IonSense’s DART-MS technology offers rapid drug analysis without the need for sample preparation.
Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.
Refeyn’s SamuxMP enables routine quantification of empty/full AAV capsid ratios, even in smaller labs, to set a new standard in AAV characterization
Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.
BenchSci, a specialist in machine learning applications for novel medicine development, has completed a Series C financing round.
Scottish biotech engineering company, uFraction8, has successfully secured more than £2.5 million ($3.3 million) in new investment.
Catalent has expanded its Malvern, Pennsylvania, USA, and Dartford, UK, facilities to provide advanced containment capabilities for the micronization of highly potent drug compounds.
January 27, 2022
Stevanato Group has extended its licensing agreement with Haselmeier for its Axis-D pen injector technology.
January 25, 2022
Merck and Ridgeback Therapeutics will supply UNICEF with up to three million capsules of molnupiravir through the first half of 2022.